Celgene, Mesoblast Extend Agreement on Proprietary Mesenchymal Lineage Adult Stem Cell Product Candidates

By: via Benzinga
Mesoblast Limited (OTC: MBLTY) today announced that it has agreed with Celgene Corporation to extend for a period of six months ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.